Multiple sclerosis (MS) and other immune-mediated conditions such as myelin oligodendrocyte glycoprotein antibody (MOG-IgG)-associated disease (MOGAD) are important differential diagnoses in clinical practice (4–6). This evidence concerns the gene MOG and myeloid sarcoma.